FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Alert on Compounded Semaglutide Overdoses

FDA warns about adverse event reports it has received that may be related to overdoses due to dosing errors associated with compounded semaglutide inj...

latest-news-card-1
Human Drugs

FDA Slaps Hold on Diabetes Investigational Drug

FDA issues a clinical hold on a vTv Therapeutics Phase 3 trial (CATT1) involving cadisegliatin (XXX DE-ITALICIZE XXX)and its use in improving glycemic...

latest-news-card-1
Medical Devices

Blog Post on Device AI Lifecycle Model

A new CDRH blog post outlines key activities that should be taking place during the lifecycle of artificial intelligence-enabled medical devices.

Medical Devices

bioMrieux Respiratory/Sore Throat Panel Cleared

FDA clears a bioMrieux 510(k) for its Biofire Spotfire Respiratory/Sore Throat Panel Mini for detecting five of the most common viral and bacterial ca...

latest-news-card-1
Human Drugs

Aurobindo Recalls Healthy Living Migraine Relief

FDA says Aurobindo has recalled one lot of its OTC Healthy Living migraine medication that was distributed through Amazon without the FDA-approved lab...

Animal Drugs

VICH Residual Solvents Guidance

FDA publishes a Veterinary International Conference on Harmonization revised guidance on residual solvents used in animal drugs.

latest-news-card-1
Federal Register

Guide on e-Health Records to Support Submissions

Federal Register notice: FDA makes available a final guidance entitled Real-World Data: Assessing Electronic Health Records and Medical Claims Data To...

latest-news-card-1
Medical Devices

Medtronic Recalls NIM Vital Nerve Monitor

Medtronics Xomed unit recalls (Class 1) its NIM Vital Nerve Monitoring system due to the potential for false negative responses.

latest-news-card-1
Biologics

Covid-19 Convalescent Plasma Guidance

FDA publishes an immediately effective guidance with its recommendations for investigational and licensed Covid-19 convalescent plasma.

latest-news-card-1
Biologics

Recommend Transition to HTS Technology: MIT Letter

Two stakeholders call for changes to an FDA draft guidance on safety testing of human allogeneic cells expanded for use in cell-based medical products...